Romeo Power, Inc.

2021 Q2 Form 10-Q Financial Statement

#000175793221000079 Filed on August 16, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2021 Q1 2020 Q2

Balance Sheet

Concept 2021 Q2 2021 Q1 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $267.7M $287.5M $5.363M
YoY Change 4891.27% 35837.5% 257.53%
Cash & Equivalents $44.05M $41.28M $5.363M
Short-Term Investments $223.6M $246.2M $0.00
Other Short-Term Assets $12.38M $10.30M $100.0K
YoY Change 12275.0% 5050.0% -66.67%
Inventory $7.615M $5.689M
Prepaid Expenses
Receivables $1.992M $1.444M
Other Receivables $6.000M $6.000M
Total Short-Term Assets $295.7M $310.9M $849.3K
YoY Change 34712.51% 30993.0% -52.82%
LONG-TERM ASSETS
Property, Plant & Equipment $6.430M $6.321M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $37.79M $38.40M
YoY Change
Other Assets $2.716M $2.893M $234.2M
YoY Change -98.84% -98.76% 23320.0%
Total Long-Term Assets $58.81M $54.48M $234.2M
YoY Change -74.88% -76.73% 0.88%
TOTAL ASSETS
Total Short-Term Assets $295.7M $310.9M $849.3K
Total Long-Term Assets $58.81M $54.48M $234.2M
Total Assets $354.5M $365.4M $235.0M
YoY Change 50.84% 55.43% 0.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.200M $5.033M $35.51K
YoY Change 22995.34% -64.5%
Accrued Expenses $4.620M $3.094M $50.00K
YoY Change 9140.0% 931.33% -75.0%
Deferred Revenue $3.123M $1.672M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.307M $2.783M
YoY Change
Total Short-Term Liabilities $26.26M $19.69M $228.3K
YoY Change 11403.45% 4821.25% -71.47%
LONG-TERM LIABILITIES
Long-Term Debt $34.00K $559.0K $0.00
YoY Change
Other Long-Term Liabilities $32.00K $0.00 $8.500M
YoY Change -99.62% -100.0% 0.0%
Total Long-Term Liabilities $66.00K $559.0K $8.500M
YoY Change -99.22% -93.42% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.26M $19.69M $228.3K
Total Long-Term Liabilities $66.00K $559.0K $8.500M
Total Liabilities $40.77M $36.83M $8.770M
YoY Change 364.92% 313.78% -5.7%
SHAREHOLDERS EQUITY
Retained Earnings -$116.1M -$89.46M -$1.841M
YoY Change 6207.74%
Common Stock $13.00K $13.00K $6.840M
YoY Change -99.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $313.7M $328.6M -$5.535M
YoY Change
Total Liabilities & Shareholders Equity $354.5M $365.4M $235.0M
YoY Change 50.84% 55.43% 0.47%

Cashflow Statement

Concept 2021 Q2 2021 Q1 2020 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001757932
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P6M
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P24M
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38795
dei Entity Registrant Name
EntityRegistrantName
ROMEO POWER, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-2289787
dei Entity Address Address Line1
EntityAddressAddressLine1
4380 Ayers Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Vernon,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90058
dei City Area Code
CityAreaCode
833
dei Local Phone Number
LocalPhoneNumber
467-2237
dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
RMO
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
134056620 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44046000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
292442000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
223636000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
0 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
213000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
238000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1992000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
841000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
7615000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
4937000 USD
CY2021Q2 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
6000000 USD
CY2020Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
6000000 USD
CY2021Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
2217000 USD
CY2020Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
0 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10158000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1269000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
295664000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
305489000 USD
CY2021Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1500000 USD
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1500000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6430000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5484000 USD
CY2021Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
37794000 USD
CY2020Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
35000000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5350000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5469000 USD
CY2021Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
5018000 USD
CY2020Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
0 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2716000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3100000 USD
CY2021Q2 us-gaap Assets
Assets
354472000 USD
CY2020Q4 us-gaap Assets
Assets
356042000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
8200000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2900000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4620000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2844000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3123000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
815000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
3307000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2260000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
855000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
853000 USD
CY2021Q2 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
6000000 USD
CY2020Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
6000000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
153000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
384000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
26258000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16056000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
34000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1082000 USD
CY2021Q2 rmo Public And Private Placement Warrants
PublicAndPrivatePlacementWarrants
9852000 USD
CY2020Q4 rmo Public And Private Placement Warrants
PublicAndPrivatePlacementWarrants
138466000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4597000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4723000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
40773000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
160344000 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
126911861 shares
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132995060 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132995060 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126911861 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
13000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
12000 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
429946000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
373129000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-155000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-116105000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-177443000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
313699000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
195698000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
354472000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
356042000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
926000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1129000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1980000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3651000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5945000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2423000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10772000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6055000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
-5019000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
-1294000 USD
us-gaap Gross Profit
GrossProfit
-8792000 USD
us-gaap Gross Profit
GrossProfit
-2404000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1792000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1594000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5563000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3396000 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22911000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2451000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
40910000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5358000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
24703000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
4045000 USD
us-gaap Operating Expenses
OperatingExpenses
46473000 USD
us-gaap Operating Expenses
OperatingExpenses
8754000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-29722000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5339000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-55265000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-11158000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
5000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
264000 USD
us-gaap Interest Expense
InterestExpense
12000 USD
us-gaap Interest Expense
InterestExpense
518000 USD
CY2021Q2 rmo Change In Fair Value Of Public And Private Placement Warrants
ChangeInFairValueOfPublicAndPrivatePlacementWarrants
1995000 USD
CY2020Q2 rmo Change In Fair Value Of Public And Private Placement Warrants
ChangeInFairValueOfPublicAndPrivatePlacementWarrants
0 USD
rmo Change In Fair Value Of Public And Private Placement Warrants
ChangeInFairValueOfPublicAndPrivatePlacementWarrants
118120000 USD
rmo Change In Fair Value Of Public And Private Placement Warrants
ChangeInFairValueOfPublicAndPrivatePlacementWarrants
0 USD
CY2021Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-379000 USD
CY2020Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-289000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
CY2021Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
CY2020Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1386000 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1386000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-28111000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6989000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
62554000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-13062000 USD
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-563000 USD
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-36000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1206000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-732000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-28674000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7025000 USD
us-gaap Net Income Loss
NetIncomeLoss
61338000 USD
us-gaap Net Income Loss
NetIncomeLoss
-13794000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
34000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-308000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
0 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-115000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-153000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
CY2021Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
149000 USD
CY2020Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-155000 USD
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131059149 shares
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28525000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7025000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
61183000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13794000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131059149 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
77396263 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129930204 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76021298 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
135021296 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77396263 shares
rmo Stock Issued During Period Value Contract Consideration
StockIssuedDuringPeriodValueContractConsideration
5018000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76021298 shares
CY2021Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
573000 USD
CY2020Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
587000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1286000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1469000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
328586000 USD
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7575000 USD
CY2021Q2 rmo Proceeds Receivable From Common Stock Issuance
ProceedsReceivableFromCommonStockIssuance
7144000 USD
CY2021Q2 rmo Stock Issued During Period Value Contract Consideration
StockIssuedDuringPeriodValueContractConsideration
5018000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8189000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
149000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-28674000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
313699000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
195698000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
44202000 USD
rmo Proceeds Receivable From Common Stock Issuance
ProceedsReceivableFromCommonStockIssuance
7144000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14742000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-155000 USD
us-gaap Net Income Loss
NetIncomeLoss
61338000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
313699000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-2642000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3757000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
375000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7025000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-5535000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2573000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5034000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
652000 USD
us-gaap Net Income Loss
NetIncomeLoss
-13794000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-5535000 USD
us-gaap Profit Loss
ProfitLoss
61338000 USD
us-gaap Profit Loss
ProfitLoss
-13794000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
999000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
950000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
990000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
14742000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
652000 USD
us-gaap Inventory Lifo Reserve Effect On Income Net
InventoryLIFOReserveEffectOnIncomeNet
1242000 USD
us-gaap Inventory Lifo Reserve Effect On Income Net
InventoryLIFOReserveEffectOnIncomeNet
0 USD
rmo Gain On Change In Fair Value Of Public And Private Placement Warrants
GainOnChangeInFairValueOfPublicAndPrivatePlacementWarrants
-118120000 USD
rmo Gain On Change In Fair Value Of Public And Private Placement Warrants
GainOnChangeInFairValueOfPublicAndPrivatePlacementWarrants
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1206000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-732000 USD
rmo Non Cash Lease Expense Of Operating Leases Payments
NonCashLeaseExpenseOfOperatingLeasesPayments
-119000 USD
rmo Non Cash Lease Expense Of Operating Leases Payments
NonCashLeaseExpenseOfOperatingLeasesPayments
-115000 USD
rmo Non Cash Finance Lease Interest Payment On Liability
NonCashFinanceLeaseInterestPaymentOnLiability
-142000 USD
rmo Non Cash Finance Lease Interest Payment On Liability
NonCashFinanceLeaseInterestPaymentOnLiability
-140000 USD
rmo Derivative Expense
DerivativeExpense
0 USD
rmo Derivative Expense
DerivativeExpense
1386000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-20000 USD
rmo Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-124000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1151000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
65000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3920000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1245000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8377000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-344000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5369000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
535000 USD
rmo Increase Decrease In Accrued Liabilities Excluding Interest Accrued On Notes Payable
IncreaseDecreaseInAccruedLiabilitiesExcludingInterestAccruedOnNotesPayable
1776000 USD
rmo Increase Decrease In Accrued Liabilities Excluding Interest Accrued On Notes Payable
IncreaseDecreaseInAccruedLiabilitiesExcludingInterestAccruedOnNotesPayable
907000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
489000 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
2217000 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2308000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
629000 USD
rmo Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-108000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
102000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43760000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8333000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
304868000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
78633000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1300000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
4000000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2113000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
603000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-231048000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-603000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1924000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3750000 USD
rmo Proceeds From Paycheck Protection Program Loan Cares Act
ProceedsFromPaycheckProtectionProgramLoanCaresAct
0 USD
rmo Proceeds From Paycheck Protection Program Loan Cares Act
ProceedsFromPaycheckProtectionProgramLoanCaresAct
3300000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5027000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5058000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
21580000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
72000 USD
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
0 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
154000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
138000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26412000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13870000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-248396000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4934000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
293942000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1929000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45546000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6863000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44046000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5363000 USD
CY2021Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1500000 USD
CY2020Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1500000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45546000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6863000 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
514000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
702000 USD
us-gaap Stock Issued1
StockIssued1
5108000 USD
us-gaap Stock Issued1
StockIssued1
0 USD
CY2020Q4 rmo Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.121730
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The preparation of financial statements in conformity with GAAP requires us to make certain estimates and assumptions for the reporting periods covered by the financial statements. These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent liabilities. Actual amounts could differ from these estimates. The condensed consolidated financial statements have been prepared under the assumption that Romeo will continue as a going concern.</span>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Reclassification of Presentation in Our Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">—Revenues of comparative prior periods in our condensed consolidated statements of operations and comprehensive (loss) income are reclassified to conform with our current revenue presentation. In the condensed consolidated statements of operations, we’ve combined related party revenues with product revenues and service revenues and disclosed the amount of related party revenues in a captioned note.</span>Reclassification of Presentation in Note 3 of our Condensed Consolidated Financial Statements—Revenues of comparative prior periods presented in Note 3 of our condensed consolidated financial statements are reclassified to conform with our current revenue presentation. Since April 1, 2021, we have presented disaggregated revenue by product and service instead of further disaggregating product by battery packs and modules.
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1672000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
815000 USD
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-702000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-819000 USD
CY2021Q2 rmo Contract With Customer Liability Increase Due To Billings
ContractWithCustomerLiabilityIncreaseDueToBillings
2153000 USD
rmo Contract With Customer Liability Increase Due To Billings
ContractWithCustomerLiabilityIncreaseDueToBillings
3127000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3123000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3123000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
554036000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
18907000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
445851000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
89278000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
554036000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
926000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1980000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1129000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3651000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
926000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1129000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1980000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3651000 USD
us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2021Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
6798000 USD
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4064000 USD
CY2021Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
356000 USD
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
531000 USD
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
461000 USD
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
342000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
7615000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
4937000 USD
CY2021Q2 us-gaap Inventory Write Down
InventoryWriteDown
800000 USD
CY2020Q2 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
us-gaap Inventory Write Down
InventoryWriteDown
1200000 USD
CY2021Q2 rmo Number Of Warrants Redeemed
NumberOfWarrantsRedeemed
7223683 shares
CY2021Q2 rmo Cash Outflow For Redemption Of Warrants
CashOutflowForRedemptionOfWarrants
72237 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8189000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
375000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14742000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
652000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
223791000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
116000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
271000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
223636000 USD
CY2021Q2 rmo Debt Securities Available For Sale Unsettled Sales
DebtSecuritiesAvailableForSaleUnsettledSales
0 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
3000 USD
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
37000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
118000 USD
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
190000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-115000 USD
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-153000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
137053000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
271000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
137053000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
271000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
101501000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
101501000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
106314000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
106235000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
15976000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
15900000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
223791000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
223636000 USD
CY2021Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P4Y6M
CY2021Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P4Y6M
CY2020Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3375000 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1130000 USD
CY2021Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
412000 USD
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
617000 USD
CY2021Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
222000 USD
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
103000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
611000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
994000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4620000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2844000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-28674000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7025000 USD
us-gaap Net Income Loss
NetIncomeLoss
61338000 USD
us-gaap Net Income Loss
NetIncomeLoss
-13794000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131059149 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
77396263 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129930204 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76021298 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5091092 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131059149 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77396263 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
135021296 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76021298 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12888560 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22173533 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7974160 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22104262 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2021Q2 rmo Number Of Individuals On Senior Leadership Team
NumberOfIndividualsOnSeniorLeadershipTeam
2 individual
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
926000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1129000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1980000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3651000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
-5019000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
-1294000 USD
us-gaap Gross Profit
GrossProfit
-8792000 USD
us-gaap Gross Profit
GrossProfit
-2404000 USD
CY2021Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
573000 USD
CY2020Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
587000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1286000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1469000 USD
CY2021Q2 us-gaap Related Party Costs
RelatedPartyCosts
474000 USD
CY2020Q2 us-gaap Related Party Costs
RelatedPartyCosts
495000 USD
us-gaap Related Party Costs
RelatedPartyCosts
1063000 USD
us-gaap Related Party Costs
RelatedPartyCosts
1245000 USD
CY2021Q2 rmo Operating Income Loss Related Parties
OperatingIncomeLossRelatedParties
99000 USD
CY2020Q2 rmo Operating Income Loss Related Parties
OperatingIncomeLossRelatedParties
92000 USD
rmo Operating Income Loss Related Parties
OperatingIncomeLossRelatedParties
223000 USD
rmo Operating Income Loss Related Parties
OperatingIncomeLossRelatedParties
224000 USD
CY2020Q3 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
6000000.0 USD
CY2020Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
6000000.0 USD
CY2021Q2 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
6000000.0 USD
CY2021Q2 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
6000000.0 USD
CY2020Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
6000000.0 USD

Files In Submission

Name View Source Status
0001757932-21-000079-index-headers.html Edgar Link pending
0001757932-21-000079-index.html Edgar Link pending
0001757932-21-000079.txt Edgar Link pending
0001757932-21-000079-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
matthewsantofferletter-m.htm Edgar Link pending
matthewsantofferletter-m001.jpg Edgar Link pending
matthewsantofferletter-m002.jpg Edgar Link pending
matthewsantofferletter-m003.jpg Edgar Link pending
matthewsantofferletter-m004.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmo-20210630.htm Edgar Link pending
rmo-20210630.xsd Edgar Link pending
rmo-20210630x10qex311.htm Edgar Link pending
rmo-20210630x10qex312.htm Edgar Link pending
rmo-20210630x10qex321.htm Edgar Link pending
rmo-20210630x10qex322.htm Edgar Link pending
rmo-20210630_cal.xml Edgar Link unprocessable
rmo-20210630_def.xml Edgar Link unprocessable
rmo-20210630_htm.xml Edgar Link completed
rmo-20210630_lab.xml Edgar Link unprocessable
rmo-20210630_pre.xml Edgar Link unprocessable
romeo-executedofferlette.htm Edgar Link pending
romeo-executedofferlette001.jpg Edgar Link pending
romeo-executedofferlette002.jpg Edgar Link pending
romeo-executedofferlette003.jpg Edgar Link pending
romeo-executedofferlette004.jpg Edgar Link pending
Show.js Edgar Link pending